Pfizer Inc Stock (PFE) Financials Data
*All numbers in millions
| Period End Date | 2026-09-27 | 2026-06-28 | 2026-03-29 | 2025-12-31 | 2025-09-28 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 10.30%16,583.00 | 15,034.00 | 14,451.00 | 17,557.00 | 16,654.00 |
| Cost Of Revenue | 1.56%4,028.00 | 4,092.00 | 3,548.00 | 5,272.00 | 4,172.00 |
3.87%3,279.00 | 3,411.00 | 2,961.00 | - | - | |
| Selling, General, and Administrative | 3.87%3,279.00 | 3,411.00 | 2,961.00 | - | - |
| Interest Income/Expense | 0.75%662.00 | 667.00 | 668.00 | 711.00 | 652.00 |
| Income/Loss From Continuing Operations Before Tax | 618.38%3,385.00 | -653.00 | 3,170.00 | -1,642.00 | 3,334.00 |
| Income Tax Expense/Benefit, Deferred | 34.85%-860.00 | -1,320.00 | -12.00 | -433.00 | -765.00 |
| Income Tax Expense/Benefit | 132.92%134.00 | -407.00 | 461.00 | -2.00 | -216.00 |
| Income/Loss From Continuing Operations After Tax | 1,422%3,251.00 | -246.00 | 2,709.00 | -1,640.00 | 3,550.00 |
| Income/Loss From Discontinued Operations, Net Of Tax | 100.00%- | 8.00 | -13.00 | - | - |
1,472%3,252.00 | -237.00 | 2,696.00 | -1,640.00 | 3,550.00 | |
| Attributable To Parent | 1,407%3,242.00 | -248.00 | 2,687.00 | -1,648.00 | 3,541.00 |
| Available To Common Stockholders, Basic | 1,407%3,242.00 | -248.00 | 2,687.00 | -1,648.00 | 3,541.00 |
| Attributable To Noncontrolling Interest | 10.00 | 10.00 | 8.00 | 8.00 | 9.00 |
| Basic Average Shares | 0.02%5,700.00 | 5,699.00 | 5,691.00 | 1.00 | 5,685.00 |
| Diluted Average Shares | 0.91%5,751.00 | 5,699.00 | 5,731.00 | 3.00 | 5,714.00 |
| Basic Earnings Per Share | 1,525%0.57 | -0.04 | 0.47 | -0.29 | 0.62 |
| Diluted Earnings Per Share | 1,500%0.56 | -0.04 | 0.47 | -0.29 | 0.62 |
| Common Stock Dividends | 100.00%- | 0.86 | - | 0.86 | - |